CERo Therapeutics Holdings, Inc. CERO
$0.01
$0.004.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 862.80K | 782.70K | 1.59M | 1.95M | 3.30M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 610.40K | 716.90K | 1.07M | 531.80K | 443.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 74.80K | 74.80K | 74.80K | 74.80K | 500.00K |
| Total Current Assets | 1.55M | 1.57M | 2.73M | 2.55M | 4.25M |
|
|
|||||
| Total Current Assets | 1.55M | 1.57M | 2.73M | 2.55M | 4.25M |
| Net Property, Plant & Equipment | 352.00K | 630.70K | 906.90K | 1.18M | 1.46M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 174.50K | 500.00K |
| Total Assets | 1.90M | 2.21M | 3.64M | 3.91M | 6.20M |
|
|
|||||
| Total Accounts Payable | 8.22M | 7.69M | 7.58M | 7.08M | 6.21M |
| Total Accrued Expenses | 444.80K | 641.10K | 647.10K | 340.70K | 365.10K |
| Short-term Debt | 14.97M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 965.00K | 461.60K | 699.10K | 931.00K | 934.30K |
| Total Finance Division Other Current Liabilities | 7.80M | 2.54M | 160.50K | 105.50K | 105.50K |
| Total Other Current Liabilities | 7.80M | 2.54M | 160.50K | 105.50K | 105.50K |
| Total Current Liabilities | 32.41M | 11.33M | 9.09M | 8.45M | 7.62M |
|
|
|||||
| Total Current Liabilities | 32.41M | 11.33M | 9.09M | 8.45M | 7.62M |
| Long-Term Debt | -- | 136.80K | -- | -- | -- |
| Short-term Debt | 14.97M | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | 218.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 32.41M | 11.46M | 9.09M | 8.45M | 7.84M |
|
|
|||||
| Common Stock & APIC | 65.97M | 80.29M | 78.13M | 73.06M | 71.31M |
| Retained Earnings | -97.75M | -96.72M | -90.84M | -86.30M | -81.44M |
| Treasury Stock & Other | -9.90K | -44.50K | -- | -- | -78.80K |
| Total Common Equity | -31.79M | -16.48M | -12.71M | -13.24M | -10.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.29M | 7.22M | 7.26M | 8.70M | 8.57M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.29M | 7.22M | 7.26M | 8.70M | 8.57M |
|
|
|||||
| Total Common Equity | -31.79M | -16.48M | -12.71M | -13.24M | -10.21M |
| Total Preferred Equity | 1.29M | 7.22M | 7.26M | 8.70M | 8.57M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.51M | -9.26M | -5.45M | -4.54M | -1.63M |
|
|
|||||